John S. Montalbano insider trades

Open-market stock purchases and sales by John S. Montalbano, Director at AbCellera Biologics Inc, from SEC Form 4 filings since Nov 18, 2020.

Track record: 67% of 9 scored buys are up 5% or more since purchase, averaging +63%.

Recent trades

DateStockTradeValue
Aug 18, 2026ABCL AbCellera Biologics IncBought$110K
Jun 11, 2026ABCL AbCellera Biologics IncBought (not open market)—
May 14, 2026ABCL AbCellera Biologics IncBought$95.4K
Nov 26, 2025ABCL AbCellera Biologics IncBought$178K

Companies traded

  • ABCL AbCellera Biologics Inc: 12 buys, last Aug 18, 2026

Get free alerts when John S. Montalbano files a new trade →